Analytic Investors’s Quest Diagnostics DGX Stock Holding History

Analytic Investors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$5.51M	Buy	+65,118	New	+$5.47M	0.06%	187
2015 Q2	–	Sell	-639,619	Closed	-$49.2M	–	579
2015 Q1	$49.2M	Sell	639,619 -10,495	-2%	-$752K	0.67%	45
2014 Q4	$43.6M	Sell	650,114 -325,742	-33%	-$20.6M	0.62%	45
2014 Q3	$59.2M	Sell	975,856 -417,310	-30%	-$25.7M	0.85%	35
2014 Q2	$81.8M	Sell	1,393,166 -260,562	-16%	-$15.3M	1.32%	14
2014 Q1	$95.8M	Buy	1,653,728 +680,986	+70%	+$36.5M	1.46%	13
2013 Q4	$52.1M	Buy	+972,742	New	+$57.7M	0.86%	33

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Analytic Investors's DGX Position: Q3 2016 in Review

Analytic Investors opened a new position in Quest Diagnostics (DGX) in Q3 2016: 65,118 shares worth $5.51M. The stake represents 0.06% of the portfolio and ranks #187 among its holdings. This is a return to the name: Analytic Investors previously reported a position in DGX as recently as Q1 2015.

Analytic Investors first reported a position in DGX in Q4 2013 and has held it in 7 quarters since. The position peaked at $95.8M in Q1 2014. 559 funds tracked by Wall St. Rank hold DGX as of Q3 2016.

Analytic Investors held 65,118 shares of Quest Diagnostics worth $5.51M as of Q3 2016.
Quest Diagnostics was a new Analytic Investors position in Q3 2016.
Quest Diagnostics made up 0.06% of Analytic Investors's portfolio in Q3 2016, its #187 holding.
Analytic Investors first reported a position in Quest Diagnostics in Q4 2013 and has held it in 7 quarters since.
Analytic Investors's Quest Diagnostics position peaked at $95.8M in Q1 2014.
559 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.